KI
GILD icon

Keystone Investors’s Gilead Sciences GILD Stock Holding History

Keystone Investors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.49M Buy
+75,116
New +$9.9M 0.51% 40
2025
Q4 		$25.5M Buy
+207,554
New +$25.2M 2.29% 12

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Keystone Investors's GILD Position: Q2 2026 in Review

Keystone Investors opened a new position in Gilead Sciences (GILD) in Q2 2026: 75,116 shares worth $9.49M. The stake represents 0.51% of the portfolio and ranks #40 among its holdings. This is a return to the name: Keystone Investors previously reported a position in GILD as recently as Q4 2025.

Keystone Investors first reported a position in GILD in Q4 2025 and has held it in 2 quarters since. The position peaked at $25.5M in Q4 2025. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Keystone Investors held 75,116 shares of Gilead Sciences worth $9.49M as of Q2 2026.
  • Gilead Sciences was a new Keystone Investors position in Q2 2026.
  • Gilead Sciences made up 0.51% of Keystone Investors's portfolio in Q2 2026, its #40 holding.
  • Keystone Investors first reported a position in Gilead Sciences in Q4 2025 and has held it in 2 quarters since.
  • Keystone Investors's Gilead Sciences position peaked at $25.5M in Q4 2025.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Keystone Investors's 13F filing for Q2 2026, filed 14 Aug 2026.